CureZone   Log On   Join
Immunomodulatory Agent for Multiple Myeloma & Myelodysplastic Syndromes
 
marykudro Views: 44
Published: 83 days ago
 

Immunomodulatory Agent for Multiple Myeloma & Myelodysplastic Syndromes


The medication lenalidomide is used to treat patients with multiple myeloma (MM), mantle cell lymphoma, and myelodysplastic syndromes (MDS). For MM it is used following at least 1 other therapy and usually along with dexamethasone. The price of lenalidomide is reasonable and can be directly purchased from any WHO-GDP & ISO certified pharmaceutical wholesaler company.

It is administered by mouth. Lenalidomide use during pregnancy may cause harm to the baby. The dose of lenalidomide may need to be adjusted in individuals with kidney problems.

 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2021  curezone.org

1.250 sec, (1)